Back to News
Market Impact: 0.05
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Source: zacks.com
Healthcare & Biotech
The article notes that the First Trust NYSE Arca Biotechnology ETF (FBT) offers passive exposure to the healthcare-biotechnology segment. The fund launched on June 19, 2006; no new performance, holdings, or market-moving information is provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- How Abdul El-Sayed would build Medicare for All, from a wealth tax to a Fed-style governing board
- BillionToOne SVP John ten Bosch sells $320,723 in stock
- CVS Plans to Break Up $117 Billion Healthcare Conglomerate
- Sight Sciences earnings missed by $0.48, revenue topped estimates
- Novo raises full-year outlook as Wegovy sales impress
- Stifel raises Zimmer Biomet stock price target on strong quarter